Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1479 publications

Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.

Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.

Journal: Immuno-oncology technology
Published: December 09, 2025

Characterization of Early Metastatic Subpopulations in Uveal Melanoma: Single-Cell Insights Into SPP1+ Cells and Their Interactions With Macrophages.

Characterization of Early Metastatic Subpopulations in Uveal Melanoma: Single-Cell Insights Into SPP1+ Cells and Their Interactions With Macrophages.

Journal: Investigative ophthalmology & visual science
Published: November 17, 2025

Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience.

Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience.

Journal: Cancers
Published: October 30, 2025

Blood-Based Cell-Free DNA in Ophthalmic Oncology.

Blood-Based Cell-Free DNA in Ophthalmic Oncology.

Journal: Translational vision science & technology
Published: October 06, 2025

Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective Study.

Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective Study.

Journal: Cancers
Published: September 25, 2025

Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8.

Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8.

Journal: International journal of molecular sciences
Published: September 21, 2025

Letter Re: "Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations".

Letter Re: "Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations".

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2025

Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report.

Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report.

Journal: ESMO open
Published: August 13, 2025

Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma.

Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma.

Journal: Cancer reports (Hoboken, N.J.)
Published: August 11, 2025

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504.

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504.

Journal: Cancers
Published: August 08, 2025

Choroidal Metastasis Presenting As Anterior and Posterior Scleritis: A Rare Manifestation of a Previously Unknown Metastatic Cutaneous Melanoma.

Choroidal Metastasis Presenting As Anterior and Posterior Scleritis: A Rare Manifestation of a Previously Unknown Metastatic Cutaneous Melanoma.

Journal: Cureus
Published: August 07, 2025

Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis.

Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis.

Journal: Targeted oncology
Published: August 04, 2025
Showing 1-12 of 1,479

Last Updated: 01/07/2026